GeoVax Labs, Inc. (GOVX) Key Statistics & Financial Ratios

GeoVax Labs, Inc. (GOVX) — Price $0.41 — Healthcare — Biotechnology — NASDAQ

Latest reported results:

Key statistics dashboard for GeoVax Labs, Inc. (GOVX). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.

GeoVax Labs, Inc. is a biotechnology company in the clinical development phase, focused on creating innovative human vaccines and immunotherapies. The firm targets both infectious diseases and various cancer types, utilizing its proprietary modified vaccinia ankara (MVA) virus-like particle (VLP) vaccine platform.

Stock Data

Price$0.41
Market Cap$3M
Enterprise Value$165736
ExchangeNASDAQ
CountryUS

Valuation Multiples

P/E Ratio-0.03
Price / Book1.05
P/S0.00
EV/EBITDA-0.01
EV/Sales0.00
EV/FCF-0.01
P/FCF-0.16
Earnings Yield-1104.21%
FCF Yield-615.19%
Dividend Yield0.00%

Profitability

Gross Margin0.00%
EBIT Margin0.00%
EBITDA Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Return on Equity-743.66%
Return on Assets-439.95%
Return on Invested Capital-985.20%
Return on Capital Employed-1063.58%

Financial Health

Current Ratio1.54
Quick Ratio1.54
Cash Ratio1.16
Debt / Equity0.18
Debt / Assets6.96%
Net Debt / EBITDA0.14
Interest Coverage0.00
Piotroski F-Score2
Altman Z-Score-42.54

Per-Share Data

Revenue per share0.00
Book Value per share0.39
Cash per share0.69
FCF per share-4.02
Tangible Book Value per share0.39
Dividend per share0.00

Analyst Consensus

Strong Buy0
Buy6
Hold1
Sell0
Strong Sell0
Total analysts7
Avg rating (1-5)0.86

Related companies: ADAP · ADTX · AIMD · ANL · APLM · BLRX · ICU

Explore sector: Healthcare · Biotechnology

More sections of GOVX: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events

Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks